Kennedy Capital Management, Inc. Kura Oncology, Inc. Transaction History

Kennedy Capital Management, Inc.

$4.27 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$7.58 - $14.38 $259,213 - $491,752	34,197 Added 43.01%	113,715 $1.64 Million
Q1 2023 May 15, 2023	BUY	$10.71 - $14.6 $547,527 - $746,395	51,123 Added 180.04%	79,518 $972,000
Q4 2022 Feb 14, 2023	BUY	$11.23 - $16.9 $318,875 - $479,875	28,395 New	28,395 $352,000
Q1 2021 May 14, 2021	SELL	$24.75 - $39.14 $1.41 Million - $2.22 Million	-56,838 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$29.0 - $41.62 $1.26 Million - $1.8 Million	-43,355 Reduced 43.27%	56,838 $1.86 Million
Q3 2020 Nov 16, 2020	SELL	$16.3 - $30.64 $6,731 - $12,654	-413 Reduced 0.41%	100,193 $3.07 Million
Q2 2020 Aug 14, 2020	SELL	$7.95 - $18.81 $35,584 - $84,193	-4,476 Reduced 4.26%	100,606 $1.64 Million
Q1 2020 May 15, 2020	SELL	$6.45 - $14.04 $28,270 - $61,537	-4,383 Reduced 4.0%	105,082 $1.05 Million
Q4 2019 Feb 14, 2020	SELL	$12.97 - $15.94 $63,280 - $77,771	-4,879 Reduced 4.27%	109,465 $1.51 Million
Q3 2019 Nov 14, 2019	SELL	$14.75 - $20.87 $105,359 - $149,074	-7,143 Reduced 5.88%	114,344 $1.74 Million
Q2 2019 Aug 14, 2019	SELL	$14.71 - $19.79 $2.21 Million - $2.98 Million	-150,572 Reduced 55.35%	121,487 $2.39 Million
Q1 2019 May 13, 2019	SELL	$13.73 - $16.87 $471,776 - $579,670	-34,361 Reduced 11.21%	272,059 $4.51 Million
Q4 2018 Feb 12, 2019	SELL	$10.6 - $17.49 $842,201 - $1.39 Million	-79,453 Reduced 20.59%	306,420 $4.3 Million
Q3 2018 Nov 14, 2018	BUY	$16.65 - $21.85 $4.8 Million - $6.31 Million	288,579 Added 296.61%	385,873 $6.75 Million
Q2 2018 Aug 14, 2018	BUY	$14.8 - $18.8 $1.44 Million - $1.83 Million	97,294 New	97,294 $1.77 Million

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

Suvretta Capital Management, LLC New York, NY

7.65M
Shares

$68.4 Million
5.88% of portfolio
Black Rock Inc. New York, NY

6.97M
Shares

$62.3 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.81M
Shares

$51.9 Million
4.92% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

5.41M
Shares

$48.4 Million
1.97% of portfolio
Paradigm Biocapital Advisors LP New York, NY

4.33M
Shares

$38.7 Million
3.05% of portfolio

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.

Account